1. Immune signatures of patients with short-, medium-, and long-term survival.
Immune signatures of patients with short-, medium-, and long-term survival. A, The fraction of tumors displaying the number of positive immune parameters (0/4, 1/4, 2/4, 3/4, or 4/4) was plotted for the three survival groups. The fraction of tumors displaying a certain immune signature differed significantly between the three survival cohorts (χ2 test, P < 0.001). B, The correlation between the immune signature and survival was analyzed by the Kaplan–Meier method. C, The correlation between immune signature was analyzed in an independent patient cohort of stage IV melanoma patients from the TCGA database by the Kaplan–Meier method.
Sara M. Melief et al. Cancer Immunol Res 2017;5:
©2017 by American Association for Cancer Research